Richman Michael 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Jan 29, 2019
Insider Transaction Report
Form 4
Richman Michael
Director
Transactions
- Award
Stock Option (right to buy)
2019-01-25+20,000→ 20,000 totalExercise: $2.74Exp: 2029-01-25→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2019-01-25$1.79/sh+6,096$10,912→ 6,096 totalExercise: $2.74From: 2019-01-25Exp: 2029-01-25→ Common Stock (6,096 underlying)
Footnotes (2)
- [F1]The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, which compensation is payable to the Reporting Person quarterly in arrears, pursuant to the Issuer's non-employee director compensation policy.
- [F2]The stock option will vest as to 100% of the underlying shares on January 25, 2020, subject to the Reporting Person's continued service as a director through the vesting date.